Dr. Harvey Cohen-Our 2nd Medical Advisory Board member

 Harvey J. Cohen was appointed the first holder of the Deborah E. Addicott – John A. Kriewall and Betsy A. Haehl Family Professor in Pediatrics in February 2007, and the Katie and Paul Dougherty Medical Director of Palliative Care in August 2010.

Dr. Cohen was previously the Chairman of the Department of Pediatrics at Stanford University, where he was the Arline and Pete Harman Professor, and the Adalyn Jay Chief of Staff at Lucile Packard Children’s Hospital. He held these posts from 1993-2006 before stepping down to return to a career of clinical care, teaching, and research.

Dr. Cohen obtained both his MD and PhD from Duke University and was a pediatric intern at the Children’s Hospital in Boston from 1970-1971. After spending two years as a Staff Associate at the National Institutes of Health, he returned to Children’s Hospital in 1973 as a pediatric resident. He completed a fellowship in Pediatric Hematology/Oncology at Children’s Hospital and the Dana Farber Cancer Institute, and was named assistant then associate professor of pediatrics at Harvard Medical School.

In 1981, Dr. Cohen was recruited to the University of Rochester School of Medicine and Dentistry where he was named the James P. Wilmot Associate Professor of Pediatric Oncology and Chief of the Division of Pediatric Oncology. He was promoted to Professor of Pediatrics in 1984 and Associate Chair for Research and Development in the Department of Pediatrics in 1987. From 1985-1990, Dr. Cohen was on the Scientific Advisory Board for St. Jude’s Children’s Research Hospital. He returned to the Board in 2000, and was its Chair from 2002 to 2006. Dr. Cohen was also a member of the NIH Hematology II Study Section and was its Chair from 1987-1988.

Dr. Cohen served on the Board of Directors of Lucile Salter Packard Children’s Hospital, and was a Board Member of the Ronald McDonald House and the Children’s Health Council in Palo Alto, California. He was a member of the Scientific Advisory Board of Montgomery Medical Venture Fund and Gamida Cell, a biotechnology company involved in expanded cord blood stem cells. He also served on the Steering and Selection Committees of the Pediatric Scientist Development Program, and he chairs the Interdisciplinary Initiatives Program Committee of Bio-X, a venture into research, education, and innovation across all scientific communities of Stanford University. He is currently a member of the Board of Trustees of the March of Dimes, the Lucile Packard Foundation for Children’s Health, and the Morgridge Institute for Research, a private not-for-profit institute dedicated to supporting interdisciplinary medical research at the University of Wisconsin.

Dr. Cohen’s research interests include: clinical trials in leukemia, mechanisms of drug resistance, and determining the roles of proteins in predicting susceptibility to, diagnosing, and treating childhood illnesses such as brain tumors, leukemia, prematurity, and inflammatory diseases. In addition, he has a long-term interest in pediatric palliative care.

Clinical Focus

• Hematology, Pediatric
• Hematology/Oncology/Stem Cell Transplant, Pediatric
• Oncology (Cancer), Pediatric
• Pediatric Hematology-Oncology

Academic Appointments

• Professor, Pediatrics – Operations
• Member, Bio-X
• Member, Child Health Research Institute
• Member, Stanford Cancer Institute

Administrative Appointments

• Chair, Stanford University School of Medicine – Pediatrics (1993 – Present)

Professional Education

• Board Certification: Hematology, American Board of Internal Medicine (1972)
• Board Certification: Internal Medicine, American Board of Internal Medicine (1972)
• Residency:Boston Children’s Hospital (1976) MA
• Residency:Boston Children’s Hospital (1974) MA
• Internship:Boston Children’s Hospital (1971) MA
• Medical Education:Duke University Medical Center (1970) NC